PALORINI, FEDERICA
PALORINI, FEDERICA
Universita' degli Studi di MILANO
Breast cancer patient perspective on opportunities and challenges of a genetic test aimed to predict radio-induced side effects before treatment : Analysis of the Italian branch of the REQUITE project
2021 L. Bellardita, R.R. Colciago, S. Frasca, M.C. De Santis, S. Gay, F. Palorini, E. La Rocca, R. Valdagni, T. Rancati, L. Lozza
Development of a Ready-to-Use Graphical Tool Based on Artificial Neural Network Classification : Application for the Prediction of Late Fecal Incontinence After Prostate Cancer Radiation Therapy
2018 M. Carrara, E. Massari, A. Cicchetti, T. Giandini, B. Avuzzi, F. Palorini, C. Stucchi, G. Fellin, P. Gabriele, V. Vavassori, C. Degli Esposti, C. Cozzarini, E. Pignoli, C. Fiorino, T. Rancati, R. Valdagni
Evaluation of mediators associated with the inflammatory response in prostate cancer patients undergoing radiotherapy
2018 N. Bedini, A. Cicchetti, F. Palorini, T. Magnani, V. Zuco, M. Pennati, E. Campi, P. Allavena, S. Pesce, S. Villa, B. Avuzzi, S. Morlino, M.E. Visentin, N. Zaffaroni, T. Rancati, R. Valdagni
Texture analysis of T1-w and T2-w MR images allows a quantitative evaluation of radiation-induced changes of internal obturator muscles after radiotherapy for prostate cancer
2018 E. Scalco, T. Rancati, I. Pirovano, A. Mastropietro, F. Palorini, A. Cicchetti, A. Messina, B. Avuzzi, R. Valdagni, G. Rizzo
Predicting Late Fecal Incontinence Risk After Radiation Therapy for Prostate Cancer : New Insights From External Independent Validation
2018 A. Cicchetti, B. Avuzzi, F. Palorini, F. Ballarini, C. Stucchi, G. Fellin, P. Gabriele, V. Vavassori, C.D. Esposti, C. Cozzarini, C. Fiorino, T. Rancati, R. Valdagni
Eleven-year management of prostate cancer patients on active surveillance : what have we learned?
2017 C. Marenghi, M. Alvisi, F. Palorini, B. Avuzzi, F. Badenchini, N. Bedini, L. Bellardita, D. Biasoni, D. Bosetti, A. Casale, M. Catanzaro, M. Colecchia, L. De Luca, S. Donegani, P. Dordoni, R. Lanocita, M. Maffezzini, T. Magnani, J. Menichetti, A. Messina, S. Morlino, B. Paolini, T. Rancati, S. Stagni, A. Tesone, T. Torelli, E. Tulli Baldoin, M. Vaiani, S. Villa, S. Villa, N. Zaffaroni, N. Nicolai, R. Salvioni, R. Valdagni
Understanding urinary toxicity after radiotherapy for prostate cancer: First steps forward
2017 T. Rancati, F. Palorini, C. Cozzarini, C. Fiorino, R. Valdagni
Multi-variable models of large International Prostate Symptom Score worsening at the end of therapy in prostate cancer radiotherapy
2016 F. Palorini, T. Rancati, C. Cozzarini, I. Improta, V. Carillo, B. Avuzzi, V. Casanova Borca, A. Botti, C. Degli Esposti, P. Franco, E. Garibaldi, G. Girelli, C. Iotti, A. Maggio, M. Palombarini, A. Pierelli, E. Pignoli, V. Vavassori, R. Valdagni, C. Fiorino
Baseline status and dose to the penile bulb predict impotence 1 year after radiotherapy for prostate cancer
2016 C. Cozzarini, T. Rancati, F. Badenchini, F. Palorini, B. Avuzzi, C. Degli Esposti, G. Girelli, I. Improta, V. Vavassori, R. Valdagni, C. Fiorino
Modelling late stool frequency and rectal pain after radical radiotherapy in prostate cancer patients : results from a large pooled population
2016 A. Cicchetti, T. Rancati, M. Ebert, C. Fiorino, F. Palorini, A. Kennedy, D. Joseph, J. Denham, V. Vavassori, G. Fellin, B. Avuzzi, C. Stucchi, R. Valdagni
First application of a pixel-wise analysis on bladder dose-surface maps in prostate cancer radiotherapy
2016 F. Palorini, C. Cozzarino, S. Gianolini, A. Botti, V. Carillo, C. Iotti, T. Rancati, R. Valdagni, C. Fiorino
Multi-variable models predicting specific patient-reported acute urinary symptoms after radiotherapy for prostate cancer : results of a cohort study
2015 C. Cozzarini, T. Rancati, V. Carillo, F. Civardi, E. Garibaldi, P. Franco, B. Avuzzi, C.D. Esposti, G. Girelli, C. Iotti, F. Palorini, V. Vavassori, R. Valdagni, C. Fiorino